U.S. Army Medical Research and Development Command clinical trials
Listed in the registry as: U.S. federal agency.
The registry lists 153 studies whose lead sponsor is U.S. Army Medical Research and Development Command. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 15, 2026.
Keep track of what changes. Save the U.S. Army Medical Research and Development Command studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions U.S. Army Medical Research and Development Command leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 153. Browse all 153 →
- Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress DisorderNot yet recruitingNCT07704762Phase 2
- Tecovirimat (ST-246) Treatment for Orthopox Virus ExposureAvailableNCT02080767
- Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy AdultsRecruitingNCT06205056Phase 1
- Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM SleepRecruitingNCT02945501Not applicable
- Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An AssessmentEnrolling by invitationNCT04474015Not applicable
- An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran SampleRecruitingNCT04180930
- Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in AdultsNot yet recruitingNCT03531242Phase 2
- Phase 2 Safety and Immunogenicity Study of Rift Valley Fever VaccineRecruitingNCT03609398Phase 2
- Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic FeverSuspendedNCT02483260Not applicable
- Treatment of Hemorrhagic Fever With RibavirinSuspendedNCT04283513Phase 2
- Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRSCompletedNCT04333459Phase 2
- Evaluation of CL Detect™ Rapid Test to Detect Cutaneous LeishmaniasisCompletedNCT01865032
- Single or Repeat Dose of G03-52-01 in Adult SubjectsCompletedNCT05348993Phase 2
- Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy AdultsCompletedNCT05423418Phase 1
- HIV Vaccine in HIV-uninfected AdultsCompletedNCT04658667Phase 1
- Is an Antiplaque Chewing Gum (30 mg) Able to Reduce Dental Plaque in a Healthy Population?CompletedNCT02864901Phase 2
- Ribavirin for Hemorrhagic Fever With Renal SyndromeWithdrawnNCT00623168Phase 2
- Combination HTNV and PUUV DNA VaccineCompletedNCT03718130Phase 1
- PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19CompletedNCT04784767Phase 1
- Tecovirimat Intravenous Treatment for Orthopox Virus ExposureNo longer availableNCT05380752
- Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)CompletedNCT02018250Phase 1
- FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4)WithdrawnNCT03867162Phase 2
- Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01BCompletedNCT02458092Phase 1
- Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)No longer availableNCT04360486
- A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04268420Phase 1
- Safety and Immunogenicity Study of Rift Valley Fever Vaccine, InactivatedCompletedNCT00869713Phase 2
- Expanded Access Remdesivir (RDV; GS-5734™)No longer availableNCT04302766
- Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive AdultsCompletedNCT01540474Phase 1
- NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1CompletedNCT00392015Phase 1/2
- Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved PlateletsCompletedNCT02078284Phase 1
- Continued Safety and Immunogenicity Study of a Live Francisella Tularensis VaccineStatus unknownNCT00787826Phase 2
- Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria InfectionCompletedNCT00761020Not applicable
- A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04296279Phase 1
- Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54CompletedNCT03882528Phase 1
- Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/EStatus unknownNCT01931358Phase 2
- Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated VaccineStatus unknownNCT03141138Phase 1
- The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Trauma PatientsStatus unknownNCT01547013
- A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA VaccineCompletedNCT02776761Phase 1
- Safety Study of Chimeric Vaccine to Prevent ETEC DiarrheaCompletedNCT01644565Phase 1
- Sodium Stibogluconate Treatment of LeishmaniasisCompletedNCT00662012Phase 2
- Ascending Doses of Autologous FDP vs FFPCompletedNCT02930226Phase 1
- Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)CompletedNCT02445963Phase 1
- Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria VaccineCompletedNCT00223990Phase 2
- A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous LeishmaniasisCompletedNCT01536795Phase 2
- Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2
- Comparison of Full-dose Flu Vaccine to Half-dose Flu VaccineCompletedNCT00283283Phase 2
- Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic FeverCompletedNCT02116205Phase 2
- Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.CompletedNCT00197054Phase 2
- Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis VaccineStatus unknownNCT00582504Phase 2
- Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy AdultsStatus unknownNCT03051386Phase 2